Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
Top Cited Papers
Open Access
- 1 December 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (12), 3907-3914
- https://doi.org/10.1182/blood.v96.12.3907
Abstract
Somatic mutations of the receptor tyrosine kinase Flt3 consisting of internal tandem duplications (ITD) occur in 20% of patients with acute myeloid lKeywords
This publication has 36 references indexed in Scilit:
- Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsBritish Journal of Haematology, 2000
- HIGH EXPRESSION BUT NO INTERNAL TANDEM DUPLICATION OF FLT3 IN NORMAL HEMATOPOIETIC CELLSPediatric Hematology and Oncology, 1999
- Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemiaLeukemia, 1999
- Phosphatidylinositol-3′ Kinase Is Not Required for Mitogenesis or Internalization of the Flt3/Flk2 Receptor Tyrosine KinasePublished by Elsevier ,1996
- Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitorsImmunity, 1995
- c-KIT expression enhances the leukemogenic potential of 32D cells.Journal of Clinical Investigation, 1995
- Biology and potential clinical applications of flt3 ligandCurrent Opinion in Hematology, 1995
- Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAsNature, 1994
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991